Dr. Ayesh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
120 SE 4th St
Evansville, IN 47708Phone+1 812-426-6638
Education & Training
- Vanderbilt University Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2022
- University of ToledoResidency, Internal Medicine, 2019 - 2022
- Johns Hopkins School of Public HealthMPH, 2019 - 2019
- OtherClass of 2015, Islamic University of Gaza
Certifications & Licensure
- IN State Medical License 2024 - 2025
- KY State Medical License 2023 - 2025
- OH State Medical License 2019 - 2022
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
- American Board of Obesity Medicine Obesity Medicine
Publications & Presentations
PubMed
- Efficacy and safety of resmetirom in MASLD and MASH: network meta-analysis of randomized clinical trials.Hazem Ayesh, Azizullah Beran, Sajida Suhail, Suhail Ayesh, Kevin Niswender
Journal of Basic and Clinical Physiology and Pharmacology. 2025-01-01 - Impact of allulose on blood glucose in type 2 diabetes: A meta-analysis of clinical trials.Hazem Ayesh, Sajida Suhail, Suhail Ayesh
Metabolism Open. 2024-12-01 - Comparative Analysis of Resmetirom vs. FGF21 Analogs vs. GLP-1 Agonists in MASLD and MASH: Network Meta-Analysis of Clinical Trials.Hazem Ayesh, Azizullah Beran, Sajida Suhail, Suhail Ayesh, Kevin Niswender
Biomedicines. 2024-10-14
Professional Memberships
- Member
- Member
- Endocrine SocietyMember
- Member
Other Languages
- Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: